Revenue (Tables)

12 Months Ended

Dec. 31, 2024

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue

The following tables disaggregate our revenue from contracts with customers by business unit and geographic region (in millions). Generally, we allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.

	Year Ended December 31,
	2024						2023						2022
Businesses	U.S.		Int'l		Total		U.S.		Int'l		Total		U.S.		Int'l		Total
Endoscopy	$	1,651	$	1,036	$	2,687	$	1,511	$	970	$	2,482	1,341		$	880	$	2,221
Urology	1,557		643		2,200		1,369		595		1,964		1,257		516		1,773
Neuromodulation	847		259		1,106		736		240		976		715		202		917
MedSurg	4,054		1,939		5,993		3,617		1,805		5,422		3,312		1,599		4,911
Interventional Cardiology Therapies	824		1,820		2,645		743		1,674		2,417		744		1,485		2,228
Watchman	1,371		145		1,516		1,155		119		1,274		915		103		1,019
Cardiac Rhythm Management	1,403		876		2,279		1,405		813		2,218		1,337		763		2,100
Electrophysiology	1,256		648		1,904		370		430		800		275		310		585
Cardiology	4,855		3,490		8,344		3,673		3,036		6,709		3,271		2,662		5,932
Peripheral Interventions	1,301		1,109		2,410		1,135		975		2,110		1,048		850		1,899
Cardiovascular	6,156		4,599		10,755		4,808		4,011		8,819		4,319		3,512		7,831
Other(1)	—		—		—		—		—		—		—		—		(60)
Total Net Sales	$	10,210	$	6,538	$	16,747	$	8,425	$	5,816	$	14,240	$	7,632	$	5,111	$	12,682

(1)    In 2022, amounts reflect sales reserves established for Italian government payback provisions, which are being disputed in the Italian court system. These amounts were not allocated to our reportable segments or considered by our CODM for resource allocation and decision-making purposes.

Refer to Note M – Segment Reporting for information on our reportable segments.

	Year Ended December 31,
Geographic Regions	2024		2023		2022
U.S.	$	10,210	$	8,425	$	7,632
Europe, Middle East and Africa	3,228		2,856		2,526
Asia-Pacific	2,686		2,400		2,116
Latin America and Canada	624		560		469
Other1	—		—		(60)
Total Net Sales	$	16,747	$	14,240	$	12,682
Emerging Markets(2)	$	2,680	$	2,310	$	1,968

(1)    In 2022, amounts reflect sales reserves established for Italian government payback provisions, which are being disputed in the Italian court system. These amounts were not allocated to our reportable segments or considered by our CODM for resource allocation and decision-making purposes.

(2) Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada.